This variability in outcomes likely stems from differences in study design, population characteristics, and follow-up duration
Still, the best choice depends on your health, medical history, treatment goals, side effect tolerance, and insurance coverage
Maximizing Health on GLP-1 Medications: The Role of Weight Training, Protein, and Creatine May 7, 2025 3 min read Medications like semaglutide (Ozempic) and tirzepatide (Mounjaro), part of the GLP-1 receptor agonist class, have revolutionized weight management and diabetes care
, Beyond pigmentation: signs of liver protection during afamelanotide treatment in Swiss patients with erythropoietic protoporphyria, an observational study, SAGE Publications, Jan
adults (12%) say that they have taken a GLP-1 drug, and 6% that say they are currently taking such medications
After 40 weeks, the average drop in HbA1c was about 1.7-1.9 percentage points for participants receiving retatrutide, compared with 0.8 with the placebo